ATXI Projected Dividend Yield
Avenue Therapeutics Inc ( NASDAQ : ATXI )Avenue Therapeutics is a pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. Co.'s product candidates include AJ201 for the treatment of spinal and bulbar muscular atrophy, intravenous Tramadol for the treatment of post-operative acute pain, and BAER-101 for the treatment of epilepsy and panic disorders. 20 YEAR PERFORMANCE RESULTS |
ATXI Dividend History Detail ATXI Dividend News ATXI Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |